🔎 Trials Near Me

Akèy › Kansè pwostat › Lwizyàn

Etid klinik pou Kansè pwostat nan Lwizyàn

23 etid pou Kansè pwostat ap chèche patisipan nan sit nan Lwizyàn.

Vil nan Lwizyàn

Tèks ofisyèl etid la (Anglè)

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • LSU Health Baton Rouge-North Clinic, Baton Rouge
  • Our Lady of the Lake Physician Group, Baton Rouge
  • Our Lady of The Lake, Baton Rouge
  • ak 7 plis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • Louisiana Hematology Oncology Associates LLC, Baton Rouge
  • Northshore Oncology Associates-Covington, Covington
  • Mary Bird Perkins Cancer Center - Metairie, Metairie
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT03866382

A Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer

  • Southern Urology LLC, Lafayette
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Sep 25, 2026 · NCT07832292

Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

  • XCancer Research Network LCMC Health EJGH, Metairie
Ap rekriteFaz 1/2
Laj 18 ak plis · Gason · Mizajou Sep 25, 2026 · NCT06800313

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

  • East Jefferson Hospital, Metairie
Ap rekriteFaz 3
Laj 18 a 100 · Gason · Mizajou Sep 22, 2026 · NCT06855277

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

  • Louisiana State University, New Orleans
  • WK Clinical Research, Shreveport
Ap rekrite
Laj 18 ak plis · Gason · Mizajou Sep 14, 2026 · NCT06511141

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

  • Mary Bird Perkins Cancer Center, Baton Rouge
  • Mary Bird Perkins Cancer Center - Gonzales, Gonzales
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 10, 2026 · NCT05946213

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

  • Ochsner Health - Ochsner Medical Center - New Orleans, New Orleans
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Sep 3, 2026 · NCT07005154

Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer

  • Research Site, Metairie
Ap rekriteFaz 1/2
Laj 18 a 99 · Gason · Mizajou Aug 27, 2026 · NCT07590934

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

  • Research Site, Metairie
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Aug 26, 2026 · NCT07611110

A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

  • Ochsner, Jefferson
Ap rekriteFaz 1/2
Laj 18 ak plis · Gason · Mizajou Aug 20, 2026 · NCT06785636

Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging

  • LSU Health Baton Rouge-North Clinic, Baton Rouge
  • Our Lady of the Lake Physician Group, Baton Rouge
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Aug 19, 2026 · NCT04423211

Water Vapor Ablation for Prostate Cancer: Long-Term Registry

  • WK Advanced Urology Specialists, Bossier City
Ap rekriteEtid obsèvasyon
Tout laj · Gason · Mizajou Aug 18, 2026 · NCT07455058

A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

  • East Jefferson General Hospital Metairie, New Orleans
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Aug 17, 2026 · NCT06842498

PSMA PET Combined With MRI for the Detection of PCa

  • Southern Urology, Lafayette
  • Ochsner Clinic Foundation, New Orleans
Ap rekriteFaz 3Volontè an sante akeyi
Laj 18 ak plis · Gason · Mizajou Jul 23, 2026 · NCT07052214

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

  • Louisiana Hematology Oncology Associates LLC, Baton Rouge
  • Mary Bird Perkins Cancer Center - Metairie, Metairie
  • University Medical Center New Orleans, New Orleans
  • ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Jul 14, 2026 · NCT06592924

Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

  • Tulane Cancer Center, New Orleans
  • Ochsner Clinic Foundation, New Orleans
Ap rekriteFaz 4
Laj 18 a 100 · Gason · Mizajou Jun 4, 2026 · NCT05803941

A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer

  • Research Site, Metairie
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou May 12, 2026 · NCT06879041

Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation

  • LSU Healthcare Network / Metairie Multi-Specialty Clinic, Metairie
  • Louisiana State University Health Science Center, New Orleans
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Jan 29, 2026 · NCT05806515

Vitamin D for Prostate Endocrine Therapy

  • Louisiana State University Health Science Center, New Orleans
  • University Medical Center New Orleans, New Orleans
  • Ochsner Medical Center Jefferson, New Orleans
Ap rekriteFaz 3
Laj 50 ak plis · Gason · Mizajou Jan 15, 2026 · NCT05838716

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, New Orleans
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

  • East Jefferson General Hospital, Metairie
  • LSU Healthcare Network / Metairie Multi-Specialty Clinic, Metairie
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 11, 2025 · NCT03678025

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.